Skip to content

Clinical trials

Phase 3 Multiple Sclerosis, Relapsing-Remitting trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Phase 3 Country / region: Czechia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20074
20081
20093
20103
20113
20132
20141
20162
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen13
Genzyme, a Sanofi Company3
Amgen1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Novartis1
Novartis Pharmaceuticals1
Sanofi1
Synthon BV1
Teva Branded Pharmaceutical Products R&D, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting24
Multiple Sclerosis13
Recurrence3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.